查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年口腔液快速篩查設備的全球市場
市場調查報告書
商品編碼
1217600

2022-2029 年口腔液快速篩查設備的全球市場

Global Rapid Oral Fluid Screening Device Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

口腔液篩查正變得越來越流行，因為它是一種無創且可直接觀察的樣本採集方法。 口腔液篩查是比尿液分析更好的功能障礙指標，因為它具有更短的檢測週期並且與血液藥物濃度的相關性更強。

市場動態

口腔液體快速篩查設備的全球市場受到口腔疾病患病率上升、技術進步、醫療設備研發、先進醫療技術的採用、患者對快速藥物篩查意識的提高以及醫療成本降低的推動。增長帶動。

藥物濫用和酒精中毒增加導致市場擴張

在預測期內，年輕人對藥物檢測和酒精中毒的需求不斷增長，將推動市場發展。 根據 2022 年發表在《科學報告》(Scientific Reports) 上的一篇文章，年輕人經常光顧酒吧、俱樂部和節日等各種夜生活場所並進行社交活動。 研究表明，精神活性物質的使用在這些環境中尤為普遍。 研究表明，非法藥物使用與大量飲酒有關。 酒精和非法藥物的使用會導致嚴重的暴力後果（包括性侵犯）、事故和死亡。 經常使用這些物質會增加患物質使用障礙等身心疾病的風險。

此外，還在澳大利亞俱樂部參與者中進行了口腔液樣本的快速現場免疫篩查測試，表明 9% 的人報告吸毒，20% 的人檢測呈陽性。我來了。 口腔液取樣是一種非侵入性方法，與血液取樣獲得的結果一致，但取樣對一些參與者來說可能很耗時，而且通常是由多種藥物或藥劑引起的。 口乾。

對口腔液檢測的好處和應用的認識和理解有限阻礙了市場增長

但是，有幾個因素可能會抑制口腔液篩查設備市場的快速增長。 這些可能包括對口腔液測試的好處和用途的認識和理解有限。 對口腔液檢測的好處和應用的認識和理解有限可能是口腔液快速篩查設備市場增長的限制因素。 由於口腔液檢測是一個相對較新且發展中的領域，許多人可能需要更好地了解它並了解其潛在用途。 因此，他們可能不太可能使用口腔液篩查設備或尋求口腔液檢測服務。 特別是，這種現象可能發生在需要熟悉先進醫療技術和習慣於診斷測試的人群中。

但是，隨著有關口腔液檢測的信息越來越多，並且越來越多的人意識到它的好處和用途，對口腔液快速篩查設備的需求可能會增加。 這可能會推動這些設備的市場增長。

COVID-19 影響分析

COVID-19 的出現對全球口腔液篩查設備市場產生了相當大的影響。 根據 2021 年發表在《臨床微生物學雜誌》上的一篇文章，對可大規模生產以進行廣泛測試並可維持 FDA 推薦的測試規範的非侵入性 SARS-CoV-2 抗體測試的需求導致了 OraSure It導致與技術合作。 OraSure Technologies 的口腔標本採集設備 (OSCD) 已經建立，用於採集和儲存針對人類免疫缺陷病毒 1 型 (HIV-1) 的口腔液抗體。 該公司的口服抗體收集裝置 (OACD) 經過改進，可用於收集針對 SARS-CoV-2 的抗體，使用含有鹽和檸檬酸的吸水墊收集牙齦和臉頰之間的口腔液。 口腔的這一部分含有富含抗體的齦溝液。 因此，在 OACD 中，通過從該部位採集樣本，可以獲得比單獨的唾液更富含抗體的口腔液樣本。

內容

第 1 章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 吸毒和酗酒現象增多
      • 更嚴格的藥物和酒精檢測法規和義務
      • 工作場所篩查在城市地區的重要性與日俱增
    • 約束因素
      • 對先進的快速唾液篩查設備的可用性缺乏認識
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 1 面板式唾液藥物檢測套件
  • 4 面板型唾液藥物檢測套件
  • 5 聯式唾液藥物檢測試劑盒
  • 6 聯式唾液藥物檢測試劑盒
  • 10 聯式唾液藥物檢測試劑盒
  • 12 聯唾液藥物檢測試劑盒

第八章形態學

  • 磁帶
  • 棉籤
  • 脫衣舞

第9章應用

  • 刑事司法考試
  • 工作場所檢查
  • 疾病檢測

第 10 章最終用戶

  • 醫院
  • 診斷機構
  • 法醫研究所
  • 獨資企業
  • 家庭醫療

第11章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第12章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 按類型劃分的基準

第13章公司簡介

  • OraSure Technologies, Inc.
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Abbott Laboratories
  • Guangzhou Wondfo Biotech Co., Ltd
  • Oranoxis Inc
  • Premier Biotech, Inc
  • UCP Biosciences, Inc.
  • SCREEN ITALIA SRL
  • Securetec Detektions-Systeme AG
  • MEDACX Ltd.
  • AccuBioTech Co. Ltd

第14章 DataM

簡介目錄
Product Code: DMMD1445

Market Overview

The global rapid oral fluid screening device market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

Oral fluid screening is increasingly popular as it is a non-invasive and directly observable sample collection method. Oral fluid screening is a better indicator of impairment as it has a shorter detection window and a stronger correlation with blood drug concentrations than urine testing.

Market Dynamics

The global rapid oral fluid screening device market is driven by the rising prevalence of oral disorders, technological advancements, research and development in medical devices, adoption of advanced healthcare technologies, improving patient awareness about rapid drug screening, and rising healthcare expenditure.

Increasing cases of drug abuse and alcoholism drives market growth

The rising demand for testing drugs and alcoholism in young adults drive the market in the forecast period. As per the article published in Scientific Reports in 2022, young adults frequently visit and socialize in different nightlife venues such as bars, clubs, and festivals. Studies have shown that psychoactive substance use is especially high in these environments. Research indicates that illicit drug use is associated with high levels of alcohol consumption. The use of alcohol and illicit drugs can lead to serious acute consequences such as violence (including sexual assault), accidents, and even death. Frequent use of these substances increases the risk of physical and mental illnesses, including substance use disorders.

In addition, an on-site immunological quick screening test of oral fluid samples has also been conducted among Australian clubgoers, demonstrating that 9% had reported drug use and 20% tested positive. Although oral fluid sampling is a non-invasive method, which agrees with the results obtained from blood sampling, sampling can be time-consuming in some participants, often due to a dry mouth, which some drugs or medications can induce.

Limited awareness and understanding about the benefits and uses of oral fluid testing will hamper the growth of the market

However, several factors could restrain the growth of the rapid oral fluid screening device market. These may include limited awareness and understanding of the benefits and uses of oral fluid testing. Limited awareness and understanding of the benefits and uses of oral fluid testing can be a factor that restrains the growth of the rapid oral fluid screening device market. Oral fluid testing is a relatively new and evolving field, and many people may need to be more familiar with it or aware of its potential applications. Resulting, they may be less likely to use oral fluid screening devices or seek out oral fluid testing services. This can be especially true in segments of the population that may need to become more familiar with advanced medical technologies or more accustomed to using diagnostic testing.

However, as more information about oral fluid testing becomes available and more people become aware of its benefits and uses, the demand for rapid oral fluid screening devices will likely increase. This could drive growth in the market for these devices.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global oral fluid screening device market. As per the article published in the Journal of Clinical Microbiology in 2021, the need for a noninvasive SARS-CoV-2 antibody test that could be mass-produced for widespread testing and maintain testing specifications recommended by the FDA led to a collaboration with OraSure Technologies. The ability of OraSure Technologies' oral specimen collection device (OSCD) to gather and preserve oral fluid antibodies against human immunodeficiency virus type 1 has previously been established (HIV-1). Their oral antibody collection device (OACD), modified for better antibody collection for antibodies against SARS-CoV-2, uses an absorbent pad containing salts and citric acid to collect oral fluid between the gums and cheeks. An antibody-rich gingival crevicular fluid is present in this area of the mouth. Therefore, by taking samples from this area, the OACD obtains oral fluid samples that are more abundant in antibodies than saliva alone.

Segment Analysis

The disease testing segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The disease testing segment accounts for the largest market share. During COVID-19, clinical and healthcare demands have been on the rapid rise. Major challenges during the pandemic have included a lack of testing kits, shortages of ventilators to treat severe cases of COVID-19, and insufficient access to personal protective equipment for hospitals and the public. Scientists, researchers, and companies have developed new technologies, including rapid oral fluid screening devices, in response to these demands-increasing demand for disease testing by using rapid oral fluid screening for diagnosis.

In addition, VerOFy & LIAM Rapid Saliva Point-of-Care Testing offers VerOFy a unique platform technology that combines rapid and standardized saliva [oral fluid] collection with high-quality immunochromatographic test strips for delivery of immediate results in the field or point-of-care locations.

Geographical Analysis

North America region holds the largest market share of the global rapid oral fluid screening device market

North America dominates the market for rapid oral fluid screening devices and is anticipated to show a similar trend over the forecast period. There are several reasons why the North American region may dominate the rapid oral fluid screening market globally. Strong healthcare infrastructure and advanced medical technologies in the region have contributed to the high adoption rate of oral fluid screening devices. The region's high prevalence of substance abuse and addiction has led to a strong demand for reliable and accurate testing methods. The availability of a wide range of rapid oral fluid screening devices in the North American market offers consumers various options-a favorable regulatory environment for the region's approval and marketing of oral fluid screening devices. High levels of healthcare spending in the North American region have helped fuel the growth of the rapid oral fluid screening market.

In addition, OraSure Technologies offers Intercept i2 Oral Fluid Collection Device that provides a 3-minute collection time (average) with a patented treated pad, no pre-collection sample pooling required, and an ergonomic collector designed for a comfortable end-user experience.

Competitive Landscape

The rapid oral fluid screening device market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are OraSure Technologies, Inc, Abbott Laboratories, Guangzhou Wondfo Biotech Co., Ltd, Oranoxis Inc, Premier Biotech, Inc, UCP Biosciences, Inc., SCREEN ITALIA SRL, Securetec Detektions-Systeme AG, MEDACX Ltd., and AccuBioTech Co. Ltd, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the rapid oral fluid screening device market globally.

For instance,

  • In April 2020, OraSure Technologies, Inc., a leader in point-of-care diagnostic tests, specimen collection devices and microbiome laboratory and analytical services, was awarded a $710,310 contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Department of Health and Human Services (HHS), to design a pan-SARS-coronavirus antigen rapid in-home self-test that uses oral fluid samples. This support from BARDA will enable OraSure to file for FDA Emergency Use Authorization (EUA), allowing an in-home self-test to debut in the U.S. market.

Abbott Laboratories

Overview:

Abbott Laboratories is a healthcare and medical device organization founded in 1888 and headquartered in the United States. For over 130 years, the company put science and innovation to work - to develop more opportunities for more people through the power of health.

Product Portfolio:

OrALert ORAL FLUID DRUG SCREEN DEVICE: The OrALert Oral Fluid Drug Screen Device is easy, quick, and provides results in under 10 minutes. Benefits include Available tests including mAMP OPI, AMP, BZO, COC, PCP and THC1, improved detection of parent THC, reliable screening for illicit and prescription drugs in saliva, minimum exposure to specimen, and split specimen well.

The global rapid oral fluid screening device market report would provide access to approximately 60+ market data tables, 60+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing cases of drug abuse and alcoholism
      • 4.1.1.2. Tougher regulations and mandates for drug and alcohol testing
      • 4.1.1.3. The growing emphasis on workplace screening among urban populations
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of awareness regarding the availability of advanced rapid saliva screening devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. 1- Panel Saliva Drug Test Kit*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. 4- Panel Saliva Drug Test Kits
  • 7.4. 5- Panel Saliva Drug Test Kits
  • 7.5. 6- Panel Saliva Drug Test Kits
  • 7.6. 10- Panel Saliva Drug Test Kits
  • 7.7. 12- Panel Saliva Drug Test Kits

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Cassettes*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Swabs
  • 8.4. Strips

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Criminal Justice Testing*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Workplace Testing
  • 9.4. Disease Testing

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Diagnostic Laboratories
  • 10.4. Forensic Laboratories
  • 10.5. Private Employers
  • 10.6. Home Care Settings

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Form
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Type Benchmarking

13. Company Profiles

  • 13.1. OraSure Technologies, Inc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Abbott Laboratories
  • 13.3. Guangzhou Wondfo Biotech Co., Ltd
  • 13.4. Oranoxis Inc
  • 13.5. Premier Biotech, Inc
  • 13.6. UCP Biosciences, Inc.
  • 13.7. SCREEN ITALIA SRL
  • 13.8. Securetec Detektions-Systeme AG
  • 13.9. MEDACX Ltd.
  • 13.10. AccuBioTech Co. Ltd

LIST NOT EXHAUSTIVE

14. Global Rapid Oral Fluid Screening Device Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us